Ignite Creation Date:
2025-12-24 @ 11:30 PM
Ignite Modification Date:
2025-12-25 @ 9:18 PM
Study NCT ID:
NCT01111656
Status:
COMPLETED
Last Update Posted:
2011-09-07
First Post:
2010-03-15
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Efficacy, Safety and Tolerability of Atorvastatin 40 mg in Patients With Relapsing-remitting Multiple Sclerosis Treated With Interferon-beta-1b
Sponsor:
Insel Gruppe AG, University Hospital Bern
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
75/07
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Prof. H. Mattle
Old Organization:
Department of Neurology, Inselspital, Bern University Hospital, and University of Bern, Switzerland